Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
04. October 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 9097
Articles 1 - 20 / 181925
Reply to Paolo Zaurito's Letter to the Editor re: Robert M. Meier, Nima Aghdam, Alan C. Beckman, et al. 10-yr Survival and Toxicity Outcomes of Stereotactic Body Radiotherapy for Prostate Cancer: A Nonrandomized Clinical Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.04.029.
Eur Urol
Meier R, Aghdam N, Kaplan I.
PMID: 42829268 [PubMed - as supplied by publisher]
Reply to Riccardo Lombardo's Letter to the Editor re: Bi-Ming He, Keqin Zhang, Zhien Zhou, et al. Cognitive Versus Software-based Fusion targeted Biopsy for the Diagnosis of Clinically Significant Prostate Cancer: A Multicenter, Randomized, Noninferiority Trial (IMAGINATION). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.06.020.
Eur Urol
He BM, Wang HF.
PMID: 42829267 [PubMed - as supplied by publisher]
PSMA-PET/CT-guided Intensification of Radiation Therapy for Prostate Cancer (PSMAgRT): 5-yr Analysis of a Phase 2 Randomized Controlled Trial.
Eur Urol
Belliveau C, Saad F, Duplan D, Petit C, Delouya G, Lambert C, Taussky D, Barkati M, Beauchemin MC, Clavel S, Mok G, Gauthier-Paré AS, Igidbashian L, Jolicoeur M, Nguyen TV, McLaughlin PY, Wong P, Keu KV, DaSilva JN, Juneau D, Ménard C.
PMID: 42829266 [PubMed - as supplied by publisher]
Re: Microultrasonography-guided Versus MRI-guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial.
Eur Urol
Girometti R, Giganti F.
PMID: 42829264 [PubMed - as supplied by publisher]
Diagnostic accuracy of (18)F-PSMA-1007 PET/CT and bone scintigraphy for detecting bone metastases in prostate cancer.
Jpn J Radiol
Kitajima K, Naka S, Hatano K, Uemura M, Sasaki H, Kamiya T, Kurimoto K, Katayama D, Kato H, Liu Y, Cardinale J, Giesel FL, Nonomura N, Watabe T.
PMID: 42828696 [PubMed - as supplied by publisher]
Oncological outcomes after Senhance robot-assisted radical prostatectomy: biochemical recurrence and risk stratification in a large single-centre cohort.
J Robot Surg
Zekulic T, Kulis T, Hudolin T, Penezic L, Andelic J, Sambolic T, Saric D, Knezevic N, Kastelan Z.
PMID: 42828655 [PubMed - indexed for MEDLINE]
Robot-assisted versus non-robotic partial nephrectomy for completely endophytic renal tumors: a systematic review and meta-analysis.
J Robot Surg
Yang JW, Wang L, Chen HM, Chen SY, Yang L.
PMID: 42828586 [PubMed - indexed for MEDLINE]
Prevalence of osteoporosis and low bone mass in men with prostate cancer: a systematic review and meta-analysis.
Support Care Cancer
Ebrahimi M, Mohammadi A, Sarmadi S, Rahimnia R, Zare-Kaseb A, Reis LO, Shabestari AN, Sanaie N, Keshtkar A, Aghamir SMK.
PMID: 42828578 [PubMed - indexed for MEDLINE]
Impact of magnetic resonance imaging-based diagnostic pathway on oncologic outcomes of localised prostate cancer between primary treatment modalities: a Will-Rogers phenomenon?
World J Urol
Yu L, Lee HJ, Lee AY, Goh JL, Tay KJ, Ho HSS, Tuan J, Yuen JSP, Chen K.
PMID: 42828553 [PubMed - indexed for MEDLINE]
PSMA PET/CT Kinetics During Systemic Therapy and Radiotherapy in Hormone-sensitive Prostate Cancer: A Systematic Review.
Eur Urol Open Sci
Le Guévelou J, Bauckneht M, Soeterik TFW, Scheltema M, Bianchi L, Kesch C, Gandaglia G, Rajwa P, Nicoletti R, Zattoni F, Martini A, Fasulo V, Kasivisvanathan V, Preisser F, Sanchez LR, Ambrosini F, Falagario U, Fazekas T, Giesen A, Rovera G, Maggi M, Mercinelli C, Miszczyk M, Rivas JG, Windisch O, Stroomberg H, Rui B, Bourgi A, Tilki D, Marra G, EAU-YAU Prostate Cancer Working Group.
PMID: 42828270 [PubMed]
Patient-derived prostate cancer organoids: model development, therapeutic applications, and challenges for precision oncology.
Front Oncol
Zhu J, Wang S, Du F, Shao S.
PMID: 42827781 [PubMed]
The cost-effectiveness of medical versus surgical androgen deprivation therapy for advanced prostate cancer in Tanzania: a Markov model-based analysis.
Front Public Health
Nyongole O, Tungu M, Kagaigai A, Anaeli A, Tindamanyile A, Njau P, Mizinduko M, Urassa D, Sunguya B, Frumence G.
PMID: 42827560 [PubMed - indexed for MEDLINE]
Radiomic model versus R.E.N.A.L. nephrometry score for predicting the likelihood of undergoing partial nephrectomy in clear cell renal cell carcinoma.
Front Urol
Liu FD, Yu HL, Wang DJ, Ju XB, Yang YH.
PMID: 42827468 [PubMed]
Imaging in Upper Tract Urothelial Carcinoma: Diagnostic Accuracy of Current Modalities for Local Tumor Staging.
Curr Urol Rep
Dudinec JV, Tan YG, Refugia JM, Nabavizadeh R, Shah AM, Abern MR, Ghoreifi A.
PMID: 42825969 [PubMed - indexed for MEDLINE]
Correction to: Prevalence of meeting aerobic physical activity and resistance training guidelines in advanced prostate cancer: a descriptive study of racial and regional disparities in the IRONMAN registry.
Support Care Cancer
Solberg A, Grydeland M, Nilsen TS, Storås AH, Davis ID, Greaves N, Anderson S, Fay AP, Chi KN, Enting D, McDermott R, Badal S, Waihenya CG, Popoola A, Lazarus JM, Mateo J, Bjartell A, Omlin A, Odedina F, Ragin C, Mucci LA, IRONMAN investigators, Russnes KM.
PMID: 42825937 [PubMed - in process]
Sexual and relational challenges in men and women affected by prostate cancer: a Project SEXUS study.
BJU Int
Lundorff IJ, Graugaard C, Fode M, Andersson M, Frisch M.
PMID: 42825355 [PubMed - as supplied by publisher]
Mechanisms of microbiome-immune interactions in bladder cancer and targeted regulatory strategies.
Front Immunol
Wu S, Fu S, Shi H, Gong Y, Chen P, Zhang X, Jiang E, Wang H.
PMID: 42824830 [PubMed - indexed for MEDLINE]
Reninoma in an adolescent boy with negative selective renal vein sampling: a case report and review of the literature.
Front Endocrinol (Lausanne)
Zhang L, Qiu D, Li J, Ma X, Xiao Y, Dong Z, Zhang Y, Zhu L, Xia Z, Lu W.
PMID: 42824143 [PubMed - indexed for MEDLINE]
Importance of time to nephrectomy in localized renal cell cancer according to histological subtype.
Minerva Urol Nephrol
Filzmayer M, Polverino F, Petix M, Quarta L, Orlandi F, Goyal JA, Longo N, Musi G, Briganti A, Micali S, Shariat SF, Humke C, Traumann MI, Wenzel M, Saad F, Chun FK, Karakiewicz PI.
PMID: 42823865 [PubMed - indexed for MEDLINE]
CAIX-targeted PET/CT in clear cell renal cell carcinoma: a systematic review of current evidence and clinical perspectives.
Minerva Urol Nephrol
Garrou F, Sacchetti GM, Leva L, Manfredi M, DE Cillis S, Fiori C.
PMID: 42823864 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 181925
Page 1 of 9097
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy